{"transactions":[{"id":919015,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-04T21:10:03.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 2, 2026 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2026, subject to the reporting person's continued service on each such vesting date."}],"balance_after":57000,"derivative":{"exercise_price":10.72,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001193125-26-037575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526037575/ownership.xml","form_type":"4"}},{"id":1153262,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-09T20:15:04.000Z","date":"2025-05-08","kind":"sale","planned":false,"acquired":false,"shares":498,"price":5.06,"value":2519.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,989 shares acquired under the Issuer's employee stock purchase plan on May 14, 2024."}],"balance_after":14062,"source":{"system":"sec-edgar","filing":"0000950170-25-068038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025068038/ownership.xml","form_type":"4"}},{"id":1292784,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-28T21:15:08.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":76120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":76120,"derivative":{"exercise_price":4.16,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":76120},"source":{"system":"sec-edgar","filing":"0000950170-25-009815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025009815/ownership.xml","form_type":"4"}},{"id":1521799,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-05-09T20:10:08.000Z","date":"2024-05-07","kind":"sale","planned":false,"acquired":false,"shares":236,"price":7.76,"value":1831.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":11571,"source":{"system":"sec-edgar","filing":"0000950170-24-056947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024056947/ownership.xml","form_type":"4"}},{"id":1585904,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-03-08T23:05:06.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":4884,"price":11.7155,"value":57218.502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.74, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 699 shares acquired under the Issuer's employee stock purchase plan on May 13, 2022."}],"balance_after":11807,"source":{"system":"sec-edgar","filing":"0000950170-24-028827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024028827/ownership.xml","form_type":"4"}},{"id":1666245,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T02:10:04.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 26, 2024 and is scheduled to vest in equal yearly installments over two years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":6.95,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-009096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024009096/ownership.xml","form_type":"4"}},{"id":1666244,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T02:10:04.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":83820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date."}],"balance_after":83820,"derivative":{"exercise_price":6.95,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":83820},"source":{"system":"sec-edgar","filing":"0000950170-24-009096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024009096/ownership.xml","form_type":"4"}},{"id":1896339,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-05-11T20:12:00.000Z","date":"2023-05-10","kind":"sale","planned":false,"acquired":false,"shares":210,"price":3.31,"value":695.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":15992,"source":{"system":"sec-edgar","filing":"0000950170-23-021245","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017023021245/ownership.xml","form_type":"4"}},{"id":2019356,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-13T21:15:26.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":16100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 9, 2023 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date."}],"balance_after":16100,"derivative":{"exercise_price":12.59,"expiration_date":"2033-02-08","underlying":"Common Stock","underlying_shares":16100},"source":{"system":"sec-edgar","filing":"0000899243-23-004744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924323004744/doc4.xml","form_type":"4"}},{"id":2205053,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-19T20:15:26.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":16540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 15, 2022 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2022, subject to the reporting person's continued service on each such vesting date."}],"balance_after":16540,"derivative":{"exercise_price":5.39,"expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":16540},"source":{"system":"sec-edgar","filing":"0000899243-22-026322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322026322/doc4.xml","form_type":"4"}},{"id":2275801,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-10T20:15:22.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":6500,"derivative":{"exercise_price":8.63,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0000899243-22-017416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322017416/doc4.xml","form_type":"4"}},{"id":2275800,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67710,"kind":"person","name":"Tourangeau Greg","position":1,"cik":"0001916566","reported_name":"Tourangeau Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Common Stock","published_at":"2022-05-10T20:15:22.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":16202,"source":{"system":"sec-edgar","filing":"0000899243-22-017416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322017416/doc4.xml","form_type":"4"}}]}